Skip to content
Open access

Governing medical AI under the EU AI Act: an integrated compliance-by-design framework

Sep 2026 · Frontiers in Digital Health · Vol 8 · 0 citations · 32 references
Medicine

TL;DR

A compliance-by-design framework is proposed that translates overlapping legal requirements into a set of auditable governance artefacts covering system classification, regulatory mapping, data governance, validation, human oversight, conformity assessment, post-market monitoring, and change control.

Abstract

Artificial intelligence (AI) is becoming an increasingly important component of healthcare, supporting diagnosis, clinical decision-making, medical imaging, triage, and patient-facing services. While these technologies offer significant opportunities to improve healthcare delivery, they also raise important questions about patient safety, fairness, privacy, transparency, cybersecurity, and accountability. This paper examines the regulatory framework governing medical AI in the European Union, focusing on the interaction between the Artificial Intelligence Act (AI Act), the Medical Device Regulation (MDR), the In Vitro Diagnostic Medical Device Regulation (IVDR), the General Data Protection Regulation (GDPR), and the European Health Data Space (EHDS). Drawing on doctrinal and conceptual regulatory analysis, it argues that many AI-enabled medical systems should be regulated through continuous lifecycle compliance rather than by relying primarily on a one-time assessment at market entry. The analysis identifies the training and validation dataset as a particularly important point of regulatory convergence, especially among the EHDS, GDPR, and AI Act data-governance requirements, and examines how responsibility is allocated across the general-purpose AI value chain under Article 25. Building on this analysis, the paper proposes a compliance-by-design framework that translates overlapping legal requirements into a set of auditable governance artefacts covering system classification, regulatory mapping, data governance, validation, human oversight, conformity assessment, post-market monitoring, and change control. The framework is illustrated through two contested use cases and complemented by recommendations tailored to the responsibilities of different stakeholder groups. The analysis incorporates Regulation (EU) 2026/1744 (Digital Omnibus on AI), while recognising that supporting guidance, harmonised standards, and implementation of the EHDS continue to evolve and should be checked when the framework is applied. The framework is conceptually derived and illustrated through constructed use cases rather than empirically validated; future work should assess its usability, consistency, and discriminating power through structured expert assessment and Delphi-based consensus methods.

Read PDF

Similar papers

Open access Sep 2026

Implications of the new US AI framework in medicine

How the new US AI framework may accelerate adoption while leaving clinically consequential tools outside traditional regulatory pathways is examined.

A. Armoundas · 0 citations
Open access Sep 2026

AI-Based In-House Medical Devices at a Regulatory Crossroads: Beneficial Regime or Legal Loophole?

The Medical Device Regulation (MDR) establishes an in-house exemption regime that allows medical devices, manufactured and used exclusively within health institutions in the European Union (EU), to be put into service with reduced regulatory requirements. This exemption excludes the need for a conformity assessment b...

Eylem Karakaya, Sofia Palmieri, E. Biasin · 0 citations
Review Aug 2026

Artificial intelligence in medicine: An ethical and legal review.

This review addresses the primary ethical principles relevant to AI in medicine - including respect for patient autonomy, beneficence, non-maleficence, and justice - alongside key legal frameworks with respect to liability, data protection, regulatory compliance, and algorithmic transparency.

Sebastian Schleidgen, O. Friedrich · 0 citations
Aug 2026

Legal Regulation of Artificial Intelligence in Healthcare: Challenges, Opportunities, and Ethical Considerations

Artificial Intelligence (AI) has emerged as a transformative technology in the healthcare sector, revolutionizing medical diagnosis, treatment planning, disease prediction, robotic surgery, personalized medicine, and healthcare administration. AI-driven technologies improve clinical efficiency, reduce human error, acce...

Research Author · 0 citations
Review Open access Sep 2026

From Regulatory Authorization to Clinical Accountability: A Control Preventability Framework for Healthcare AI

A Control–Preventability Principle is proposed that allocates accountability according to control, foreseeability, preventability, and meaningful oversight capacity across developers, deploying institutions, and clinicians, with accountability following control over preventable risk rather than merely the physical loca...

Tony T. Williams, Amna Jatoi, Sazain Malik et al. · 0 citations
Open access Aug 2026

Overcoming the opaque side of AI in healthcare: a lifecycle based approach.

This work proposes nine operational measures - covering transparency-oriented risk and change control, traceability, subgroup and independent validation, usability-based explainability, calibrated clinical evaluation, structured labeling, version-controlled updates, and regulated end-of-life data handling - to support...

E. Bianchini, L. Billeci, Noemi Conditi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.